These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Ferrières J; Lambert J; Lussier-Cacan S; Davignon J Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440 [TBL] [Abstract][Full Text] [Related]
4. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men. Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490 [TBL] [Abstract][Full Text] [Related]
5. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131 [TBL] [Abstract][Full Text] [Related]
6. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Gaudet D; Vohl MC; Perron P; Tremblay G; Gagné C; Lesiège D; Bergeron J; Moorjani S; Després JP Circulation; 1998 Mar; 97(9):871-7. PubMed ID: 9521335 [TBL] [Abstract][Full Text] [Related]
7. Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis. Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Mateo-Gallego R; Bea AM; Perez-Calahorra S; Marco-Benedi V; Civeira F J Steroid Biochem Mol Biol; 2017 May; 169():226-233. PubMed ID: 27769814 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance. Yanagi K; Yamashita S; Kihara S; Nakamura T; Nozaki S; Nagai Y; Funahashi T; Kameda-Takemura K; Ueyama Y; Jiao S; Kubo M; Tokunaga K; Matsuzawa Y Atherosclerosis; 1997 Jul; 132(1):43-51. PubMed ID: 9247358 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization. Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350 [TBL] [Abstract][Full Text] [Related]
10. Remnant-like particles and coronary artery disease in familial hypercholesterolemia. Tada H; Kawashiri MA; Nohara A; Sakata K; Inazu A; Mabuchi H; Yamagishi M; Hayashi K Clin Chim Acta; 2018 Jul; 482():120-123. PubMed ID: 29626436 [TBL] [Abstract][Full Text] [Related]
11. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians. Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657 [TBL] [Abstract][Full Text] [Related]
12. Development of coronary atherosclerosis in asymptomatic heterozygous patients with familial hypercholesterolemia. Miida T; Nakamura Y; Okada M J Cardiol; 1996 Aug; 28(2):71-7. PubMed ID: 8814524 [TBL] [Abstract][Full Text] [Related]
13. Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia. Bos S; Phillips M; Watts GF; Verhoeven AJM; Sijbrands EJG; Ward NC J Clin Lipidol; 2017; 11(3):682-693. PubMed ID: 28434814 [TBL] [Abstract][Full Text] [Related]
14. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. Watanabe A; Yoshimura A; Wakasugi T; Tatami R; Ueda K; Ueda R; Haba T; Kametani T; Koizumi J; Ito S; Ohta M; Miyamoto S; Mabuchi H; Takeda R Atherosclerosis; 1981; 38(3-4):283-90. PubMed ID: 7225167 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of peripheral vascular disease in familial hypercholesterolaemia. Kroon AA; Ajubi N; van Asten WN; Stalenhoef AF J Intern Med; 1995 Nov; 238(5):451-9. PubMed ID: 7595185 [TBL] [Abstract][Full Text] [Related]
16. Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol. Tanno N; Oikawa S; Koizumi M; Kotake H; Hirakawa H; Kanazawa Y; Toyota T Dig Dis Sci; 1994 Jul; 39(7):1586-91. PubMed ID: 8026274 [TBL] [Abstract][Full Text] [Related]
17. Guidelines for the management of familial hypercholesterolemia. Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242 [TBL] [Abstract][Full Text] [Related]
18. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia; Einarsson K; Hellström K; Kallner M J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491 [TBL] [Abstract][Full Text] [Related]
19. Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet. Stacpoole PW; Grundy SM; Swift LL; Greene HL; Slonim AE; Burr IM J Clin Invest; 1981 Nov; 68(5):1166-71. PubMed ID: 7298845 [TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia. Sebestjen M; Zegura B; Guzic-Salobir B; Keber I Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]